Get started
RocketTickers

FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nightti

Long
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)  
RocketTickers  
NASDAQ:VNDA   Vanda Pharmaceuticals Inc.
Beyond Technical Analysis
0
0
beyondta
VNDA: Vanda Pharmaceuticals Inc.
2020-12-01 18:22:00
FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.